Telephone-Based Coaching Sessions (TAC) to Improve Advance Care Planning Participation in Advanced Cancer Patients and Their Caregivers

NCT ID: NCT07141407

Last Updated: 2026-01-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2026-04-01

Study Completion Date

2026-12-14

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This clinical trial studies whether telephone-based coaching sessions, Talking About Cancer (TAC), work to improve engagement in advance care planning (ACP) in patients with cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) and their caregivers. Participation in ACP, which includes having end of life (EOL) care conversations and completing advance directives (e.g., living will, health care proxy, do not resuscitate order), improves quality EOL care. Despite this, less than half of patients with advanced cancer have EOL care conversations or complete advance directives. TAC coaching sessions are delivered by a social worker over the phone. They are designed to help patients and their caregivers communicate about ACP, manage the distress these conversations can cause, and participate in the process of ACP with a clear action plan of having goals-of-care conversations and completing advance directives. This may be an effective way to improve ACP participation in advanced cancer patients and their caregivers.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

OUTLINE: Participants are randomized to 1 of 2 arms.

ARM I: Participants attend Talking About Cancer (TAC) telephone-based coaching sessions (2 sessions) designed to support participants in communicating about advance care planning (ACP), managing distress around ACP conversations, engaging in the process of ACP, and completing advance directives over 45-60 minutes each once a week (QW) for 2 weeks.

ARM II: Participants receive an ACP brochure/handout on study.

After completion of study intervention, participants are followed up at 6- and 12-weeks post-randomization.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Advanced Malignant Solid Neoplasm Hematopoietic and Lymphatic System Neoplasm

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Caregivers
The study project coordinator will oversee randomization and the research coordinator conducting assessments will remain blind to the condition to which the participant is assigned.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Arm I (TAC sessions)

Participants attend Talking About Cancer (TAC) telephone-based coaching sessions (2 sessions) designed to support participants in communicating about advance care planning (ACP), managing distress around ACP conversations, engaging in the process of ACP, and completing advance directives over 45-60 minutes each once a week (QW) for 2 weeks.

Group Type EXPERIMENTAL

Supportive Care

Intervention Type OTHER

Attend TAC telephone-based coaching sessions

Telephone-Based Intervention

Intervention Type BEHAVIORAL

Attend TAC telephone-based coaching sessions

Survey Administration

Intervention Type OTHER

Ancillary studies

Arm II (enhanced usual care)

Participants receive an ACP brochure/handout on study.

Group Type ACTIVE_COMPARATOR

Survey Administration

Intervention Type OTHER

Ancillary studies

Educational Intervention

Intervention Type OTHER

Receive an ACP brochure/handout

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Supportive Care

Attend TAC telephone-based coaching sessions

Intervention Type OTHER

Telephone-Based Intervention

Attend TAC telephone-based coaching sessions

Intervention Type BEHAVIORAL

Survey Administration

Ancillary studies

Intervention Type OTHER

Educational Intervention

Receive an ACP brochure/handout

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Supportive Therapy Symptom Management Therapy, Supportive Education for Intervention Intervention by Education Intervention through Education Intervention, Educational

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* PATIENT: Current diagnosis of stage III or IV cancer
* PATIENT: Able to provide informed consent
* PATIENT: Fluent in English or Spanish
* PATIENT: Have access to a telephone or computer with internet access
* CAREGIVER: Person patient indicates provides support
* CAREGIVER: English or Spanish speaking
* CAREGIVER: 18 years of age or older
* CAREGIVER: Able to provide informed consent

Exclusion Criteria

* PATIENT: Too ill or weak to complete the interviews (as judged by the interviewer)
* PATIENT: Receiving hospice at the time of enrollment
* PATIENT: Younger than age 18
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fred Hutchinson Cancer Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Megan Shen, PhD

Role: PRINCIPAL_INVESTIGATOR

Fred Hutch/University of Washington Cancer Consortium

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Fred Hutch/University of Washington Cancer Consortium

Seattle, Washington, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Megan Shen, PhD

Role: CONTACT

206-667-4172

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Megan Shen, PhD

Role: primary

206-667-4172

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RG1125666

Identifier Type: -

Identifier Source: org_study_id

NCI-2025-05520

Identifier Type: REGISTRY

Identifier Source: secondary_id

FHIRB0020936

Identifier Type: OTHER

Identifier Source: secondary_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

RCT of QPS vs General Information Sheet
NCT03287492 ACTIVE_NOT_RECRUITING NA